Invesco’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $681M | Buy |
1,438,525
+300,346
| +26% | +$151M | 0.07% | 247 |
|
|
2025
Q4 | $531M | Buy |
1,138,179
+37,250
| +3% | +$17.3M | 0.05% | 293 |
|
|
2025
Q3 | $469M | Buy |
1,100,929
+11,829
| +1% | +$4.58M | 0.07% | 314 |
|
|
2025
Q2 | $417M | Sell |
1,089,100
-113,115
| -9% | -$40.8M | 0.07% | 348 |
|
|
2025
Q1 | $415M | Sell |
1,202,215
-154,302
| -11% | -$49.6M | 0.08% | 326 |
|
|
2024
Q4 | $407M | Sell |
1,356,517
-228,529
| -14% | -$79.9M | 0.08% | 329 |
|
|
2024
Q3 | $644M | Sell |
1,585,046
-54,856
| -3% | -$20.1M | 0.12% | 181 |
|
|
2024
Q2 | $527M | Sell |
1,639,902
-19,793
| -1% | -$6.43M | 0.11% | 206 |
|
|
2024
Q1 | $554M | Sell |
1,659,695
-61,170
| -4% | -$18.7M | 0.12% | 201 |
|
|
2023
Q4 | $466M | Sell |
1,720,865
-425,979
| -20% | -$105M | 0.11% | 232 |
|
|
2023
Q3 | $528M | Buy |
2,146,844
+102,025
| +5% | +$27.9M | 0.14% | 159 |
|
|
2023
Q2 | $621M | Sell |
2,044,819
-410,360
| -17% | -$114M | 0.16% | 133 |
|
|
2023
Q1 | $647M | Sell |
2,455,179
-417,437
| -15% | -$106M | 0.18% | 116 |
|
|
2022
Q4 | $689M | Buy |
2,872,616
+307,187
| +12% | +$68.8M | 0.2% | 102 |
|
|
2022
Q3 | $472M | Sell |
2,565,429
-499,374
| -16% | -$99.5M | 0.15% | 152 |
|
|
2022
Q2 | $515M | Sell |
3,064,803
-1,126,927
| -27% | -$242M | 0.16% | 141 |
|
|
2022
Q1 | $1.05B | Buy |
4,191,730
+236,488
| +6% | +$59.4M | 0.27% | 59 |
|
|
2021
Q4 | $1.02B | Sell |
3,955,242
-308,580
| -7% | -$75.5M | 0.25% | 69 |
|
|
2021
Q3 | $1.03B | Sell |
4,263,822
-1,368,588
| -24% | -$335M | 0.26% | 67 |
|
|
2021
Q2 | $1.16B | Sell |
5,632,410
-242,049
| -4% | -$49.3M | 0.29% | 49 |
|
|
2021
Q1 | $1.11B | Sell |
5,874,459
-158,522
| -3% | -$28M | 0.3% | 47 |
|
|
2020
Q4 | $992M | Sell |
6,032,981
-151,382
| -2% | -$22.1M | 0.29% | 54 |
|
|
2020
Q3 | $771M | Buy |
6,184,363
+254,127
| +4% | +$31.5M | 0.26% | 65 |
|
|
2020
Q2 | $576M | Buy |
5,930,236
+4,721,217
| +390% | +$491M | 0.21% | 101 |
|
|
2020
Q1 | $109M | Sell |
1,209,019
-277,710
| -19% | -$36M | 0.05% | 476 |
|
|
2019
Q4 | $220M | Sell |
1,486,729
-692,017
| -32% | -$92.9M | 0.07% | 370 |
|
|
2019
Q3 | $262M | Sell |
2,178,746
-377,038
| -15% | -$48.7M | 0.07% | 345 |
|
|
2019
Q2 | $345M | Buy |
2,555,784
+121,955
| +5% | +$15.4M | 0.09% | 266 |
|
|
2019
Q1 | $317M | Sell |
2,433,829
-279,646
| -10% | -$37.6M | 0.11% | 220 |
|
|
2018
Q4 | $338M | Buy |
2,713,475
+370,689
| +16% | +$49.8M | 0.13% | 175 |
|
|
2018
Q3 | $326M | Buy |
2,342,786
+198,476
| +9% | +$24.7M | 0.1% | 210 |
|
|
2018
Q2 | $220M | Buy |
2,144,310
+142,322
| +7% | +$14.4M | 0.07% | 301 |
|
|
2018
Q1 | $194M | Sell |
2,001,988
-141,701
| -7% | -$13.7M | 0.07% | 290 |
|
|
2017
Q4 | $188M | Sell |
2,143,689
-56,644
| -3% | -$4.55M | 0.07% | 311 |
|
|
2017
Q3 | $175M | Sell |
2,200,333
-228,340
| -9% | -$18.4M | 0.06% | 331 |
|
|
2017
Q2 | $212M | Sell |
2,428,673
-51,431
| -2% | -$4.35M | 0.07% | 298 |
|
|
2017
Q1 | $221M | Buy |
2,480,104
+322
| +0% | +$26.8K | 0.07% | 288 |
|
|
2016
Q4 | $184M | Sell |
2,479,782
-81,026
| -3% | -$6.07M | 0.06% | 318 |
|
|
2016
Q3 | $194M | Sell |
2,560,808
-283,073
| -10% | -$21.7M | 0.07% | 309 |
|
|
2016
Q2 | $219M | Sell |
2,843,881
-119,125
| -4% | -$9.4M | 0.08% | 274 |
|
|
2016
Q1 | $231M | Sell |
2,963,006
-26,714
| -0.9% | -$1.87M | 0.09% | 245 |
|
|
2015
Q4 | $202M | Sell |
2,989,720
-2,417,929
| -45% | -$169M | 0.08% | 282 |
|
|
2015
Q3 | $418M | Sell |
5,407,649
-179,981
| -3% | -$15.9M | 0.18% | 123 |
|
|
2015
Q2 | $507M | Buy |
5,587,630
+1,469,813
| +36% | +$118M | 0.2% | 112 |
|
|
2015
Q1 | $310M | Sell |
4,117,817
-1,359,687
| -25% | -$97.6M | 0.12% | 207 |
|
|
2014
Q4 | $402M | Sell |
5,477,504
-409,939
| -7% | -$28.8M | 0.16% | 150 |
|
|
2014
Q3 | $415M | Sell |
5,887,443
-1,398,461
| -19% | -$92.4M | 0.17% | 134 |
|
|
2014
Q2 | $411M | Buy |
7,285,904
+128,810
| +2% | +$6.8M | 0.16% | 143 |
|
|
2014
Q1 | $376M | Sell |
7,157,094
-126,298
| -2% | -$6.29M | 0.15% | 146 |
|
|
2013
Q4 | $347M | Buy |
7,283,392
+884,143
| +14% | +$40.9M | 0.14% | 160 |
|
|
2013
Q3 | $274M | Buy |
6,399,249
+2,961,119
| +86% | +$116M | 0.12% | 201 |
|
|
2013
Q2 | $124M | Buy |
+3,438,130
| New | +$133M | 0.06% | 371 |
|
Other funds holding HCA
VCM
VPM
Invesco's HCA Position: Q1 2026 in Review
Invesco increased its HCA Healthcare (HCA) stake by 26% in Q1 2026, buying an estimated $151M and bringing the position to 1,438,525 shares worth $681M. The position accounts for 0.07% of the portfolio, ranked #247.
Invesco first reported a position in HCA in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.16B in Q2 2021. 1,415 funds tracked by Wall St. Rank hold HCA as of Q1 2026.
- Invesco held 1,438,525 shares of HCA Healthcare worth $681M as of Q1 2026.
- Invesco bought 300,346 HCA Healthcare shares in Q1 2026, an estimated $151M.
- HCA Healthcare made up 0.07% of Invesco's portfolio in Q1 2026, its #247 holding.
- Invesco first reported a position in HCA Healthcare in Q2 2013 and has held it in 52 quarters since.
- Invesco's HCA Healthcare position peaked at $1.16B in Q2 2021.
- 1,415 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.
Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.